Connect
MJA
MJA

The carbon footprint of pathology testing

Michael Dray, Daman Langguth and Tony Badrick
Med J Aust 2020; 213 (10): . || doi: 10.5694/mja2.50830
Published online: 16 November 2020

To the Editor: The Royal College of Pathologists of Australasia (RCPA) is concerned with some of the conclusions drawn in the article by McAlister and colleagues.1 We support the suggestion that there are opportunities for reducing waste and carbon dioxide emissions in pathology laboratories and, with the RCPA Quality Assurance Programs, we encourage laboratories to reduce their environmental impact whenever possible. There are laboratories already active in this space.2,3 Furthermore, we unequivocally support and encourage clinicians to exercise due consideration in choosing appropriate pathology tests. However, the reduction of pathology testing purely to reduce carbon footprint brings significant public health and economic consequences to the community.

  • Michael Dray1
  • Daman Langguth1
  • Tony Badrick2

  • 1 Royal College of Pathologists of Australasia, Sydney, NSW
  • 2 Royal College of Pathologists of Australasia Quality Assurance Programs, Sydney, NSW

Correspondence: president@rcpa.edu.au

Competing interests:

Michael Dray is a consultant histopathologist at Waikato Hospital, Hamilton, New Zealand, and is President of the Royal College of Pathologists of Australasia. Daman Langguth is a partner in Sullivan Nicolaides Pathology, Brisbane, Australia.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.